Status:
WITHDRAWN
Management of Eczema by Specific Probiotic Strains
Lead Sponsor:
Agentschap NL
Conditions:
Eczema
Atopic Dermatitis
Eligibility:
All Genders
1-15 years
Phase:
PHASE3
Brief Summary
To investigate the therapeutic effect of a selected probiotic mixture on the severity of AD in infants aged 0-15 months. The probiotic mixture has been studied in laboratory setting and has proven IL-...
Detailed Description
Atopic dermatitis (AD) is a highly prevalent chronic, itching, inflammatory skin disease that often presents in infancy. The disease can be the first manifestation of the so-called atopic march, the n...
Eligibility Criteria
Inclusion
- children 0-15 months with mild to moderate eczema (SCORAD score 15-50 or equally EASI score) for at least two weeks
Exclusion
- use of topical steroids class II or higher (which means treatment for severe eczema),
- use of oral steroids or treatment with antibiotics prior to inclusion.
- severe comorbidity
- lack of knowledge of the Dutch language
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01230190
Start Date
March 1 2011
End Date
July 1 2011
Last Update
January 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, Netherlands, 3430 EM